|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.
There are no as such competitors for Kymera Therapeutics.
The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by UBS on May 21, 2021. The analyst firm set a price target for 80.00 expecting KYMR to rise to within 12 months (a possible 58.26% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $50.55 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Kymera Therapeutics.
There is no upcoming split for Kymera Therapeutics.
Kymera Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.